Find & Manage Your Patient Assistance Programs
Estimated patient savings $600,000,000.00
Leuprolide acetate and Lidocaine HCl implant

Important Note

The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. Consult your healthcare professional before using this drug.





Leuprolide is used to treat the symptoms of prostate cancer. It works be suppressing the hormone, testosterone, that helps the cancer grow. The medication is contained in a device that is implanted into your upper arm by your doctor and releases leuprolide gradually over time (1 year). Leuprolide implant is not a cure for prostate cancer.

How To Use

Review the leuprolide implant Patient Information Leaflet. If you have any questions on the use of this product, consult your doctor. This medication device is surgically inserted under the skin of the upper arm by your doctor. The implant releases medication into your body slowly and continuously over 12 months. After 12 months, your doctor will surgically remove the old implant and may replace it with a new implant, if needed. Consult your doctor for details. It is very important to keep the bandage in place for several days until the surgical incision heals. Keep the incision clean and dry; avoid bathing and swimming for 24 hours after the procedure. Also, avoid any heavy lifting, bumping of the injection site, or physical activity for 48 hours after the procedure.

Side Effects

Hot flashes/sweating, irritation at the implant site (e.g., bruising, burning, redness, itching, minor bleeding), headache, diarrhea, or a temporary increase in the symptoms of prostate cancer (e.g., bone pain, bladder pain, tingling/numbness in the legs, problems urinating) may occur. If any of these effects persist or worsen, notify your doctor promptly. Promptly tell your doctor if any of these side effects occur: breast pain, breast enlargement, hair loss, decreased sexual ability. Tell your doctor immediately if any of these serious side effects occur: unusual bleeding or pain, mental/mood changes, unusual weakness/fatigue, swelling, weight gain, trouble breathing, fever, paralysis. Tell your doctor immediately if any of these highly unlikely but very serious side effects occur: severe headache, vision changes, severe drowsiness, unusual or one-sided weakness. An allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of an allergic reaction include: rash, itching, swelling, dizziness, trouble breathing. If you notice other effects not listed above, contact your doctor or pharmacist.


Tell your doctor your medical history, especially of: bleeding problems, bone or spine problems (e.g., vertebral lesions), urinary problems (e.g., bladder obstruction), any allergies. This medication is not recommended for use in women or children and may even cause fetal harm in pregnant women. Consult your doctor for details.

Drug Interactions

Tell your doctor of all prescription and nonprescription medication you may use. This product can affect the results of certain lab tests (e.g., pituitary/gonadal function). Make sure laboratory personnel and your doctors know you use this product. Do not start or stop any medicine without doctor or pharmacist approval.


This medication device may be harmful if swallowed. If such an accident should occur, contact the local poison control center or emergency room immediately.


Laboratory and/or medical tests (e.g., serum testosterone levels, PSA levels) may be performed to monitor your progress. If you have radiology tests (x-rays) or MRI performed, this device will not be affected or affect the results of these exams.

Missed Dose

Not applicable.


Before implantation, store at room temperature between 59 and 86 degrees F (15 and 30 degrees C) away from heat and moisture.

Medical Alert

Your condition can cause complications in a medical emergency. For enrollment information call MedicAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada).